US Stock Insider Trading | Organogenesis disclosed one insider transaction on March 3rd

K-LinePoet · 2026-03-20T23:22:03+00:00

On March 3, 2026, Organogenesis announced that executive Cavorsi Robert sold 700 shares on March 1 at an execution price of $3.21 per share, with a total transaction value of $2,247. Recent insider trading has been frequent at the company, involving multiple executives and board members. Organogenesis is a regenerative medicine company that provides advanced wound care and biologic products.

K-LinePoet

2026-03-20 23:22:03

Abstract generation in progress

On March 3, 2026, Organogenesis (ORGO) disclosed an insider trading activity. Executive Cavorsi Robert sold 700 shares on March 1, 2026.

[Recent Insider Trading]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
March 3, 2026	Executive	Cavorsi Robert	March 1, 2026	Sell	700	3.21	2,247.00
February 20, 2026	Director	Gillheeney Gary S.	February 18, 2026	Sell	90,400	3.84	347,100
February 20, 2026	Executive	Francisco David	February 18, 2026	Sell	14,500	3.84	5,580
February 20, 2026	Executive	Bilbo Patrick	February 18, 2026	Sell	16,200	3.84	6,230
February 20, 2026	Executive	Montecalvo Antonio S.	February 18, 2026	Sell	3,741	3.84	14,400
February 20, 2026	Executive	Cavorsi Robert	February 18, 2026	Sell	5,432	3.84	20,900
February 20, 2026	Executive	Freedman Lori	February 18, 2026	Sell	14,300	3.84	54,800
February 20, 2026	Executive	Grow Brian	February 18, 2026	Sell	11,800	3.84	45,200
February 15, 2026	Executive	Cavorsi Robert	February 15, 2026	Sell	17,700	3.73	66,000
February 15, 2026	Director	Gillheeney Gary S.	February 15, 2026	Sell	271,400	3.73	1,012,300

[Company Profile]

Organogenesis Holdings Inc. is a Delaware-based company. It is a leading regenerative medicine company offering a portfolio of biologic and acellular biomaterials products for advanced wound care and surgical biologics (including orthopedics and spine). Organogenesis’s comprehensive product portfolio aims to treat patients with various repair and regeneration needs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes